| Name | Address | City |
|---|---|---|
| Teresa J. Kang, LCSW | 1554 W Van Buren St | Phoenix |
| 2nd Chance Treatment Center | 16620 N 40th St STE E-1 | Phoenix |
| Intensive Treatment Systems West | 4136 N 75th Ave. Ste 116 | Phoenix |
| CleanSlate Outpatient Addiction Medicine Arizona | 8410 W Thomas Rd Ste 124 | Phoenix |
| BHG Phoenix Treatment Center | 1501 East Washington St. | Phoenix |
| Community Medical Services- Phoenix on Cactus | 2806 West Cactus Road | Phoenix |
| Connections AZ | 3333 N 7th Ave | Phoenix |
| MSCO Maricopa County Sheriff’s Office-Estrella Jail | 2939 W Durango | Phoenix |
| Towers Jail | 3127 W. Gibson Lane | Phoenix |
| Valle del Sol | 1209 S. 1st. Ave. | Phoenix |
| Soba Mesa Drug Rehab Detox and Addiction Recovery | 6262 East Broadway Road, Suite 110 | Mesa |
| Community Medical Services Tempe | 2525 S Rural Rd | Tempe |
| Center For Behavioral Health – Tempe | 2123 E Southern Avenue | Tempe |
| Intensive Treatment Systems | 340 W University Dr Suite 19 | Mesa |
| Canyon Vista Recovery Center | 860 N Center St | Mesa |
| Dr. Warren Tripp – Nevy Health | 1140 South San Jose, Suite B | Mesa |
| Aspire | 1012 South Stapley Drive, Building 5, Suite 117 | Mesa |
| Lifeline Professional Counseling | 1423 South Higley Road, Suite 103 | Mesa |
| SMC Recovery | 10207 N Scottsdale Rd | Scottsdale |
| Community Medical Services Buckeye | 213 Monroe Ave | Buckeye |
No results found!
Opioid use disorder treatment in Phoenix
Phoenix is the largest treatment market in Arizona, and you have real choices here. The Valley is home to round-the-clock opioid treatment programs and a dense network of office-based prescribers who write buprenorphine (Suboxone), and AHCCCS, Arizona’s Medicaid program, covers all three FDA-approved medications for opioid use disorder. The listings on this page show local providers; the sections below explain what kind of treatment each offers, what to expect when you start, and what current Arizona rules mean for take-home doses, telehealth, and cost.
Three medications, two settings: what the listings actually represent
Three medications are FDA-approved to treat opioid use disorder, and they are not interchangeable. Methadone is a full opioid agonist, dispensed only through a federally certified opioid treatment program (OTP), not a regular pharmacy. You go to the clinic for dosing, daily at first, with take-homes earned over time. Buprenorphine, including the Suboxone film, the buprenorphine-naloxone tablet, and the monthly Sublocade injection, is a partial agonist. It can be prescribed in a doctor’s office and filled at a pharmacy, or provided through an OTP. Naltrexone, including the monthly Vivitrol injection, is not an opioid at all; it blocks opioid effects. Any licensed prescriber can write it, and you start only after you have been off opioids long enough to avoid sudden withdrawal.
The two settings work differently. Opioid treatment programs offer same-day medical dosing, on-site counseling, and (for stable patients) eventual take-homes. How methadone and Suboxone compare is the most useful starting point if you are weighing the two. Office-based opioid treatment, sometimes called OBOT, means seeing a clinician for a prescription and picking up medication at a pharmacy. Most office-based prescribers handle buprenorphine and naltrexone; methadone for OUD stays at the opioid treatment program. Choosing the right combination is a decision to make with a clinician, not a marketer.
Starting treatment this week in Phoenix
The first call is the hardest part. Intake usually means a same-day or next-day assessment, a brief medical history, a urine drug screen, and a plan for your first dose. If you have been using fentanyl, the timing of your first buprenorphine dose matters: starting too soon can trigger sudden, severe withdrawal (precipitated withdrawal), so a clinician will time it carefully or recommend an alternative induction strategy. Methadone induction is more gradual and happens at the OTP. Arizona’s 24-hour OTPs serve AHCCCS members, the uninsured, and people whose insurance does not cover MAT, which is one reason same-day access is more realistic in Phoenix than in much of the state. For background on how medication actually helps people stop using illicit opioids, the page on methadone treatment for fentanyl walks through what the first weeks look like.
Take-home doses, telehealth, and what changed in 2024 and 2025
Federal rules updated in 2024 (42 CFR Part 8) expanded take-home methadone to up to a 28-day supply for patients who are stable in treatment, on a graduated schedule earlier in care. The same revision allowed OTPs to start treatment by telehealth (audio-visual for methadone, audio-only or audio-visual for buprenorphine) and removed the older requirement that a person have a one-year history of opioid addiction before admission. For buprenorphine specifically, DEA and HHS finalized a permanent telemedicine rule that took effect December 31, 2025, and a separate Fourth Temporary Extension keeps the broader telehealth flexibilities in place through December 31, 2026. The practical effect: you can usually start Suboxone through telehealth, including by phone in many cases, without a prior in-person visit. Methadone for OUD is still dispensed only through an OTP. Whether you qualify for take-homes is decided by your program based on stability, not by you choosing it from a menu. Why staying on your dose matters covers the clinical reasoning behind that judgment.
Paying for treatment: AHCCCS, private insurance, and block-grant funding
AHCCCS (the Arizona Health Care Cost Containment System) covers methadone, buprenorphine, and naltrexone for opioid use disorder, along with counseling, peer support, and case management. About 94% of AHCCCS members receive these services through a managed care plan; your assigned plan determines the network. If you are uninsured, Arizona’s 24-hour OTPs are funded to serve you regardless of coverage, in part through the Governor’s Office of Substance Use Disorder Service Funds and the SAMHSA Substance Abuse Block Grant. Most office-based prescribers take commercial insurance and Medicare; sliding-scale and discount programs are common at the larger community providers. Costs vary by setting and medication, so ask before your first appointment.
Phoenix and Maricopa County: the local overdose picture
Maricopa County has the largest population in Arizona and the largest absolute number of fatal overdoses. The Maricopa County Department of Public Health (MCDPH) reported that fentanyl was involved in 59% of fatal overdoses in 2024, and methamphetamine in 67%, often in combination. Statewide, opioid overdose deaths fell to 1,651 in 2024, a 13.8% decrease from 2022, according to Arizona Department of Health Services preliminary data. Phoenix is one of six Maricopa County cities with its own MCDPH fatal-overdose dashboard. The trend is downward, but the burden is still high, and most fatal overdoses now involve more than one substance. The point of these numbers is not to alarm; it is to say that medication treatment is the most effective response we have to opioid addiction, and Phoenix has more of it than nearly any other city in the Mountain West.
Pregnancy, jail-to-community continuity, and other specific situations
If you are pregnant and using opioids, methadone or buprenorphine is the standard of care, and starting treatment is safer for you and the fetus than trying to stop without help. Maricopa Safe Healthy Infants and Families Thrive (Maricopa SHIFT) connects pregnant and postpartum people with providers who treat substance use during the perinatal period, and Hushabye Nursery in Phoenix specializes in care for newborns experiencing neonatal opioid withdrawal syndrome (NOWS) alongside their parents. Arizona’s Plan of Safe Care framework is meant to coordinate prenatal care, treatment, and family support; methadone and pregnancy covers the clinical picture in more depth, and information for families can help a loved one understand what you are deciding.
If you are coming out of jail, Maricopa County Correctional Health Services runs OTP-certified programs at four county jails (Estrella, Lower Buckeye, Towers, and 4th Avenue), continues methadone treatment for people who were already in a community program before arrest, and starts MAT for people at high risk of return to use before release. That continuity matters, because the weeks after release carry the highest overdose risk. If you are on probation, in drug court, or have a court-ordered assessment, OTPs and office-based programs in Phoenix routinely document attendance and progress for referral sources.
Naloxone, fentanyl test strips, and overdose response in Phoenix
Naloxone (Narcan) reverses an opioid overdose and is the single most important thing to have on hand if you or someone you live with uses opioids, including counterfeit pills. Arizona has a statewide pharmacy standing order under A.R.S. 36-2266, which means you can get naloxone at any participating pharmacy without a personal prescription, and A.R.S. 36-2267 protects anyone who administers it in good faith. Sonoran Prevention Works, the Phoenix-based harm reduction nonprofit that has distributed more than a million doses of naloxone across Arizona since 2017, will mail kits free to people who do not live near an outreach site and offers free fentanyl test strips. The City of Phoenix directs residents to Sonoran Prevention Works and the Substance Use Coalition Leaders of Arizona for community distribution. If you have started or are restarting MOUD treatment, your tolerance drops fast; having naloxone nearby is not pessimism, it is planning. The methadone overdose page explains how the medication interacts with other depressants and what to watch for.
Common questions about MOUD treatment in Phoenix
Can I get methadone at a pharmacy in Phoenix?
No. Methadone for opioid use disorder is dispensed only through a federally certified opioid treatment program. Methadone prescribed for pain is a different pathway and not relevant to OUD treatment. Buprenorphine (Suboxone) and naltrexone, by contrast, are filled at regular pharmacies once a clinician prescribes them.
How fast can I start treatment?
Often the same day or the next day. Arizona’s 24-hour OTPs are designed for immediate intake, and many office-based prescribers in the Valley can start buprenorphine via telehealth without a prior in-person visit. Walk-in intake hours and induction protocols vary; call the program for current availability.
Will my AHCCCS plan cover Suboxone or Vivitrol?
Yes. AHCCCS covers all three FDA-approved medications for opioid use disorder. Your specific managed care plan determines which providers are in-network and whether prior authorization applies to a particular formulation; the plan’s member services line can confirm before your first visit.
Do I have to come to the clinic every day?
Not forever. Federal rules updated in 2024 allow up to 28 days of take-home methadone for patients who are stable in treatment, with shorter take-home windows earlier in care. Eligibility is decided by the program based on your progress, not by request. See methadone maintenance treatment for what longer-term care looks like.
What is the difference between Suboxone and methadone for someone who has been using fentanyl?
Both work, and which fits you depends on your medical history, what you have tried before, and your clinician’s judgment. Methadone is a full agonist started at an OTP and adjusted gradually; buprenorphine is a partial agonist that requires careful timing of the first dose to avoid precipitated withdrawal after fentanyl use. The questions and answers hub covers the trade-offs in detail.
Can I be denied treatment if I am still using?
No. Federal rules no longer require a one-year history of opioid addiction before OTP admission, and active use is the reason to start treatment, not a barrier to it. Providers expect to meet you where you are.
Sources and disclosures
Last reviewed: June 2026.
Sources:
- Substance Abuse and Mental Health Services Administration (SAMHSA), 42 CFR Part 8 final rule, 2024.
- Drug Enforcement Administration and Department of Health and Human Services, Expansion of Buprenorphine Treatment via Telemedicine Encounter, final rule effective December 31, 2025; Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities, effective through December 31, 2026.
- Arizona Health Care Cost Containment System (AHCCCS), Medical Policy Manual Chapter 600, Opioid Treatment Programs, and Locating Treatment.
- Maricopa County Department of Public Health, Fatal Overdose Data Dashboard (data compiled December 2025) and Overdose Fatality Review Board annual reports.
- Arizona Department of Health Services, Opioid Overdoses Surveillance Report, 2023 (April 2025); preliminary 2024 mortality data, June 2025.
- Maricopa County Correctional Health Services, Initiatives page.
- Sonoran Prevention Works (spwaz.org), Arizona Naloxone program.
- Arizona Revised Statutes 36-2266 (pharmacy standing order for naloxone) and 36-2267 (civil liability protection).
- Maricopa County Department of Public Health, Substance Use and Maricopa SHIFT initiative.
Not a provider: Methadone Centers is a directory and educational resource, not a medical provider. The information on this page is for general education and is not medical advice. Decisions about which medication, setting, or program is right for you should be made with a licensed clinician.
Helpline disclosure: Calls to the helpline displayed on this site are answered by paid advertisers who provide addiction treatment services. We may receive compensation from providers we list. Listings on this page do not imply endorsement.